Abstract
Word Count: 250/250
Manuscript Word Count: x/5000
Table & Figure Count (max 5): x tables, y figures, z supplementary tables/figures
HIGHLIGHTS
• CAN-PROTECT is a longitudinal online study of risk and resilience to brain aging
• Neuropsychological testing and health- and aging-related outcomes are obtained
• Data presented are from the first 2150 participants, mean age 62.9 (77.6% female)
• Associations between cognition, behaviour, function, and quality of life were found
• CAN-PROTECT is a feasible platform to obtain participant and study partner data
. CC-BY-NC 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)preprint
The copyright holder for thisthis version posted December 17, 2023. ; https://doi.org/10.1101/2023.12.16.23300094doi: medRxiv preprint
NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.
2
Abstract
Background: Preventing or reducing the risk of cognitive decline and dementia is of great public
health interest. Longitudinal data from diverse samples are needed to properly inform clinicians,
researchers, and policy makers. CAN-PROTECT is a recently launched online observational
cohort study that assesses factors contributing to both risk for incident cognitive decline and
dementia and resilience against brain aging, in participants across the lifespan.
Methods
Measures of cognition, behaviour, and quality of life administered to both participants
and study partners were compared using partial Spearman correlations adjusted for participant
and study partner age, sex, and education. In participants, relationships between cognition,
behaviour, function, and quality of life were examined using adjusted multivariable linear and
negative binomial regression models.
Results
In the first three-month window, 2150 participants spanning all Canadian provinces
enrolled; 637 nominated study partners had already completed assessments. Engagement with
the study was excellent, with many optional assessments completed. Initial analyses
demonstrated relationships between cognition, behaviour, function, and quality of life.
Discussion
These preliminary results speak to the utility and feasibility of CAN-PROTECT to
obtain data relevant to brain health, highlighting the public interest in participating in studies on
cognition. The online portal facilitated participation of a geographically diverse sample. This
group is ideal to study brain aging, dementia prevention, and early detection of
neurodegenerative disease. Longitudinal data will provide additional insights. Several features of
CAN-PROTECT are important to consider in terms of assessing risk and resilience in Canadians,
and for further development and recruitment of a research-ready cohort.
Keywords
online cohort study, brain aging, dementia, risk factors, cognitive reserve, cognitive
decline
. CC-BY-NC 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)preprint
The copyright holder for thisthis version posted December 17, 2023. ; https://doi.org/10.1101/2023.12.16.23300094doi: medRxiv preprint
3
Introduction
Alzheimer disease and other related dementias are devastating conditions, affecting both
individuals and carers, resulting in major public health implications, and requiring substantial
health care resources.[1] The emergence of disease-modifying drugs has provided some hope,
however, these are complicated and labour-intensive therapies.[2] Thus, there remains great
interest in prevention[3, 4], and improving our understanding of the aging brain is critical.
Identifying means of preventing or reducing the risk of cognitive decline and dementia could
have great benefits at individual and public health levels.[5]
While cognitive function is known to decline naturally with age, changes in memory,
reasoning, or attention can be of concern to older adults and their loved ones. Indeed, age is the
primary risk factor for incident cognitive decline and dementia, but there are many other
potential contributors to risk.[5] Several major environmental risk factors for cognitive decline
and dementia have been defined through large epidemiological and cohort studies. These factors
include cardiovascular disease, depression, diabetes, dyslipidemia, hearing impairment,
hypertension, obesity, and stroke[6-9]. Lifestyle factors have also been identified as significant
drivers of cognitive health including physical inactivity and smoking tobacco.[8-14] More
recently, the worldwide COVID-19 pandemic resulted in a great stress on older adults at risk for
dementia and may have been a contributor to risk.[15]
However, personal, environmental, and lifestyle factors can also confer resilience.[16]
Cognitive training[17], key dietary components like vitamin D[18] and B, antioxidants and
unsaturated fatty acids[8], stimulating leisure activities, and rich social networks[19] may be
protective factors. Cognitive reserve is a construct that helps operationalize the identification of
these environmental and individual factors.[20] Building cognitive reserve starts in childhood
. CC-BY-NC 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)preprint
The copyright holder for thisthis version posted December 17, 2023. ; https://doi.org/10.1101/2023.12.16.23300094doi: medRxiv preprint
4
(thus, dementia prevention starts in childhood too). Events across the lifespan further contribute
to reserve building such as enriching childhood experiences, level and quality of education[21],
complexity of occupation[22], and social and cognitive activity across the life-course.[23]
Building on cognitive reserve, the scaffolding theory of aging is a multi-faceted multi-
dimensional model that includes activities that build reserve, as well as those that reduce
neuroplasticity.[24] In essence, this model incorporates risk and resilience, both of which are
important factors to address.
How best to combine factors for risk and resilience to predict cognitive, behavioural, and
functional performance in later life is a pressing issue. There remains insufficient understanding
of the specific mechanisms that distinguish healthy and pathological aging. But observation and
assessment of change needs to start in advance of age related cognitive and physical decline, as
early as possible in the life course. Evidence that may inform clinical services, education, and
public health policy needs to incorporate country-wide and region-specific factors in an
ethnoculturally diverse sample, distributed across our broad geography, and collected across the
lifespan. The CAN-PROTECT study aims to provide this evidence.
Methods
2.1 Study Design
CAN-PROTECT (www.can-protect.ca
) is an online longitudinal observational cohort
study of brain aging in community-dwelling individuals. CAN-PROTECT was developed in
conjunction with the developers of the UK PROTECT study (www.protectstudy.org.uk), which
is aimed at identifying factors that predict cognitive aging and dementia.[25] While there are
many common elements between the two studies (e.g., neuropsychological testing, aging- and
. CC-BY-NC 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)preprint
The copyright holder for thisthis version posted December 17, 2023. ; https://doi.org/10.1101/2023.12.16.23300094doi: medRxiv preprint
5
fitness-related questionnaires, physical health, lifestyle, past mental health history), CAN-
PROTECT has a Canadian focus[26] and a novel assessment battery. The study includes novel
assessments developed to extend the assessment of risk and resilience (e.g., new scales for
quality of life, function, cognition, cognitive reserve, occupational assessment, anxious distress,
and COVID-related measures, amongst others), and a unique battery of caregiver and care
partner assessments (informed by experience in care settings). Collectively, the assessments were
tailored to the broad geography, ethnocultural makeup, and needs of Canadian adults.
Consistent with the need to collect longitudinal data across the lifespan, all adults age
≥ 18 years are potentially eligible for enrolment. Participants are excluded if they have an
established diagnosis of dementia or cannot provide informed consent. Participants can register
and participate in the study without immediately having a study partner, although they are
encouraged to find a study partner as soon as possible. Study partners must have known
participants for
≥ 5 years. In addition to serving as a partner for a CAN-PROTECT participant,
study partners can also register as CAN-PROTECT participants and name their own study
partner (who may or may not be the person who named them as a study partner). Participants
must be residents of Canada, have access to a computer or tablet with internet, and have a unique
email address to participate in the study.
Study consent, registration, and completion of study assessments are all completed
electronically. Participants and their study partners are individually asked to provide informed
consent as part of the online registration process, during which they must read through a
downloadable information sheet prior to checking off on the website a form containing
mandatory and optional consent boxes. Optional items of the consent form include contact for
newsletters and future studies, and warnings for significant drops in objective cognitive
. CC-BY-NC 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)preprint
The copyright holder for thisthis version posted December 17, 2023. ; https://doi.org/10.1101/2023.12.16.23300094doi: medRxiv preprint
6
performance. Once registered, study participants first complete the demographics assessment and
a cognitive test battery. Thereafter, participants can register for sub-studies, which at present
comprise a caregiver study. Participants in the caregiver study are offered additional assessments
about their history and experiences as current or former caregivers. Caregiver participants can be
formal caregivers and care providers (e.g., paid companion, health care aid, personal care aid, or
personal support worker, home care staff, licensed practical nurse, recreational therapist,
occupational therapist, registered nurse, nurse practitioner, or physician) and/or informal
caregivers (e.g., friend or family care partner). In total, the online registration and consent
process takes approximately 20 minutes. The Conjoint Health Research Ethics Board at the
University of Calgary Ethics provided approval for CAN-PROTECT (REB21-1065).
Participants are recruited from a variety of sources including local communication
channels (media publicity, university press partners, online content); existing study cohorts and
trials hosted by the University of Calgary; posters in primary care, geriatric, and memory clinics;
strategic targeting of nation-wide seniors’ and Alzheimer disease resource centres; and social
media platforms. The target sample size is >5000 participant-study partner dyads.
Participants receive ongoing communications to ensure that they complete their regular
assessments and to maintain engagement in the study. These include automated assessment
reminders, ad-hoc assessment notifications, regular newsletters, and access to the CAN-
PROTECT YouTube channel. Participants can receive cognitive monitoring through an
automated flagging system that identifies participants performing significantly lower than
expected on at least two cognitive tasks on at least two separate occasions. In this scenario, the
data will be examined and potentially unblinded for CAN-PROTECT study clinicians to contact
. CC-BY-NC 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)preprint
The copyright holder for thisthis version posted December 17, 2023. ; https://doi.org/10.1101/2023.12.16.23300094doi: medRxiv preprint
7
flagged participants. Currently, the study is only administered in English, with plans for a
French-language version in the future.
2.2 Study Assessments
Following registration and consent, participants receive email reminders to log into their
individual study page to access the assessments. The initial assessment is for baseline
demographics, after which participants gain access to the cognitive test battery, which is
mandatory to continue the study. The battery consists of Trail-Making B, Switching Stroop, Self-
Ordered-Search, Paired Associate Learning, Verbal Reasoning, and Digit Span tasks. With the
exception of Trail-Making B and Switching Stroop, these tasks have been developed and
validated in online settings.[25] Together, the battery measures cognitive domains of executive
function, attention, task-switching, visual episodic memory, verbal reasoning, and working
memory.[27-32] Participants must complete the cognitive test battery annually. While a
complete cognitive battery comprises three test sessions in one week a minimum of 12 hours
apart, only one test session is required to continue the study. There is a 50-minute time limit to
complete each battery and a restriction to a one-week window to complete the cognitive battery,
which are designed to optimize the quality of the cognitive test data.
After completing the cognitive test battery, participants gain access to the 16 remaining
questionnaires, which they can complete in any order thy choose. Questionnaires assess
subjective cognition, behaviour, function, quality of life, medical history, diet, lifestyle, physical
fitness, fertility/menopause, COVID-19, family history of dementia, brain injury, mental health,
and perceived health feelings and attitudes toward aging (described in detail in Table 1).
Completing a cognitive battery test session also unlocks registration into sub-studies, which
provides access to additional questionnaires. Formal caregivers complete a scale specific to
. CC-BY-NC 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)preprint
The copyright holder for thisthis version posted December 17, 2023. ; https://doi.org/10.1101/2023.12.16.23300094doi: medRxiv preprint
8
caregiver burden in professional caregivers as well as a caregiving history and current
employment status questionnaire. Informal caregivers complete a caregiver burden scale, as well
as questionnaires on caregiver resources and supports and entry to role as a care provider.
Only 8 of the 17 participant questionnaires are mandatory, one of which is only available
for female or transmen participants, allowing participants to easily tailor their involvement in the
study. Furthermore, all questionnaires, can be completed over multiple sittings should the
participant choose to begin but not complete them immediately. Participants are also able to
freely navigate forwards and backwards across questionnaire items and revise their answers, if
necessary, prior to submitting the assessment.
Annual follow-up assessments are completed through the online study platform. The
annual assessment includes re-administration of the cognitive test battery, 13 of the
questionnaires administered at baseline (the other four are baseline-only), and the caregiver
assessments (for participants who are also caregivers). The baseline assessments take
approximately 60-120 minutes, depending on how many optional assessments are completed. An
additional 20 minutes is required for those completing the supplementary caregiver assessments.
Annual follow-up assessments are expected to take approximately 90 minutes.
Study partners complete a questionnaire on their own demographics. Thereafter, they are
offered questionnaires based on observations of participant cognition, behaviour, function,
quality of life, and general health. Study partner questionnaires are similar to participant
questionnaires, but are third person, often containing fewer questions than the corresponding
participant questionnaires.
. CC-BY-NC 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)preprint
The copyright holder for thisthis version posted December 17, 2023. ; https://doi.org/10.1101/2023.12.16.23300094doi: medRxiv preprint
9
Participants can withdraw from the study at any time through the online study platform.
In this scenario, participants may retain or destroy any personal identifiable information, but the
anonymized research assessment data are retained. Participant withdrawal will also lead to
automatic withdrawal of their study partner. Likewise, withdrawn study partner research
assessment data are retained.
2.3 Data Management
All data are collected online using the custom-built CAN-PROTECT study platform.
Responses to questionnaires are obtained using tick-boxes, thermometer scales, or restricted
numeric data entry. Several measures have been implemented at this stage to optimize the quality
of the data. These measures include numeric variables restricted to valid ranges (e.g., 18-130
years for age), skip logic for questions that are mutually exclusive (e.g., skipping questions about
specific North American ethnocultural background subgroups if no North American origins are
initially reported); and answer selection logic for responses that are mutually exclusive so that
they cannot be simultaneously selected. All these measures were tested extensively prior to study
launch across multiple individuals, devices, and browsers. Whenever a new update to the online
study platform is launched, these assessments are tested extensively again to ensure high data
quality and integrity.
After data collection, all personal identifiable data are stored separately from the research
assessment data, with no means of linking the two datasets via the database. The research data
are then anonymized prior to data extraction and analysis. Backups of the data are created daily,
and the data are extracted from the database ~monthly to ensure that users have regular access to
the most up-to-date data available.
. CC-BY-NC 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)preprint
The copyright holder for thisthis version posted December 17, 2023. ; https://doi.org/10.1101/2023.12.16.23300094doi: medRxiv preprint
10
Quality control after the initial data extraction was performed manually to ensure that all
variable values were coded in alignment with the detailed data dictionary and that all variable
distributions were plausible. During testing, it was confirmed that the selection of specific
responses to questionnaires corresponded exactly with the variable values expected based on the
data dictionary. Subsequent data extractions are quality controlled via a three-step semi-
automated pipeline. The first step is to determine whether any variables have been added to or
removed from the dataset before evaluating all variable values against the data dictionary.
Second, statistical comparisons between corresponding variables across data extractions are
performed to determine whether the distributions of any variables have deviated significantly
from a previous data extraction. Third, the pipeline generates a report of the results, which
includes relevant data visualizations. This report is manually reviewed by a data team member to
ensure there are no unexpected deviations from previous data extractions, after which the data
are released for analysis.
2.4 Statistical Analysis
Statistical methods for CAN-PROTECT data are tailored for each individual analysis or
study question. In this initial report, we analyzed data from the initial wave of participant aged
≥ 40 years. We provide a descriptive statistical analysis of the data pertaining to demographics,
geographic distribution, optional consents, assessment completion, as well as cognition,
behaviour, function, and quality of life in study participants, caregivers, and study partners.
Cognition was measured in participants according to their performance on the six objective
cognitive of the battery as well as the revised Everyday Cognition (ECog-II) scale.[33]
Behaviour was measured using the Mild Behavioral Impairment Checklist (MBI-C).[34, 35]
Individuals were defined as having mild behavioral impairment (MBI) based on a validated
. CC-BY-NC 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)preprint
The copyright holder for thisthis version posted December 17, 2023. ; https://doi.org/10.1101/2023.12.16.23300094doi: medRxiv preprint
11
MBI-C cut-off score ≥ 8 for dementia-free individuals.[36, 37] Function was measured using the
Morris & Morris assessment for instrumental activities of daily living in older adults.[38] Quality
of life was measured using the EuroQoL-5D-5L (EQ-5D).[39]
Descriptive statistics included numbers and percentages for categorical variables and
means, standard deviations (SD), and ranges for numeric variables, stratified by study
participants, caregivers, and study partners. Measures of cognition, behaviour, and quality of life
that were administered to both participants and study partners were compared using partial
Spearman correlations adjusting for participant and study partner age, sex, and education. Within
participants only, the relationships between cognition, behaviour, and function were examined
using multivariable linear or negative binomial regression models, as appropriate, adjusting for
participant age, sex, and education.
Results
3.1 Demographics
In the first three months after study launch, 2150 participants
≥ 40 years of age (of whom
50 are caregivers) as well as 637 study partners registered in the study and had completed at least
one assessment (Table 2). The mean±SD participant age was 62.9±9.3 years old and participants
had completed 15.8±5.8 years of education, on average. A majority of participants reported
female sex at birth (77.6%), and only three participants (0.1%) reported a non-binary or other
gender. English was the most common first language of participants (92.0%), followed by Other
(5.6%) and then French (2.4%). Participants tended to be Married (69.2%), although 30.8%
reported a marital status other than Married (30.8%), which may include being widowed,
separated, divorced, common-law, cohabitating, single, or never married. Right hand dominance
. CC-BY-NC 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)preprint
The copyright holder for thisthis version posted December 17, 2023. ; https://doi.org/10.1101/2023.12.16.23300094doi: medRxiv preprint
12
was reported by 86.7% of participants, with left hand dominance in 11.0% and ambidexterity in
2.3%. Ethnocultural origins were not mutually exclusive; the most frequently reported were from
Europe (83.8%), North America (49.2%), Asia (3.2%), Caribbean (1.1%), South America
(0.9%), Africa (0.9%), and Oceania (0.6%). Within North America, 3.2% were First Nations,
0.1% were Inuit, 3.4% were Métis, 91.2% were Canadian, while 6.4% identified as being from
the United States. Demographic characteristics of the caregiver subgroup were relatively
consistent with those of the overall study participant cohort. In contrast, study partners were
slightly younger (58.5±13.9 years) and more evenly distributed across sexes (54.5% female).
The majority of participants reside in the Canadian provinces of Alberta (n=652; 30.3%),
Ontario (n=562; 26.1%), and British Columbia (n=477; 22.2%). The remaining 459 (21.3%)
participants are relatively evenly distributed across all other Canadian provinces. Most
participants reported hearing about the CAN-PROTECT study through media publicity (n=1309;
60.9%) followed by Other (n=488; 22.7%), and word of mouth (n=273; 12.7%). Nearly all
participants (96.0%) consented to receiving automated flagging system notifications for
significant drops in cognitive test performance, 93.4% signed up for the study newsletters, and
just over three-quarters (75.5%) of participants consented to being contacted for future studies.
3.2 Engagement with platform
Of the 2150 participants 1586 (73.8%) had completed the first cognitive test battery,
1064 (49.5%) the second, and 721 (33.5%) the third by the time of data extraction. Of the 1586
(73.8%) participants who completed the first cognitive test battery, which was required to access
the rest of the assessments, the majority went on to complete nearly all 17 baseline participant
assessments. The most frequently completed assessment was the Everyday Activities
questionnaire (n=1539; 71.6%). The least frequently completed was the Perceived Health
. CC-BY-NC 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)preprint
The copyright holder for thisthis version posted December 17, 2023. ; https://doi.org/10.1101/2023.12.16.23300094doi: medRxiv preprint
13
Feelings and Attitudes Toward Aging questionnaire (n=890; 41.4%), which was only applicable
to participants older than 65, followed by the Physical Fitness test (n=1070; 49.8%). Among
caregivers, 48 (96.0%) completed the Care Partner Stress Scale, 43 (86.0%) the Care Partner
Resources and Supports questionnaire, 37 (72.0%) the Caregiver Work History and Roles
questionnaire, and 5 (10.0%) the Paid Caregiver Stress Scale. Among study partners, the
Everyday Emotions questionnaire was the most frequently completed assessment (n=637; 100%)
and the Participant Health was the least frequently completed assessment (n=588; 92.3%).
3.2 Cognition, Behaviour, Function, and Quality of Life
Participants took a mean of 62.3±24.0 seconds to complete the Trail-Making B cognitive
test. Average summary performance scores were 38.1±15.0 seconds for Switching Stroop,
6.5±2.7 seconds for Self-Ordered Search, 3.9±0.9 seconds for Paired Associates Learning,
31.4±10.0 seconds for Verbal Reasoning, and 6.9±1.9 for Digit Span. The average total ECog-II
score was 12.0±11.5 (with higher scores denoting greater impairment). Across domains, average
ECog-II scores were 4.7±3.9 for memory, 3.2±3.5 for language, 0.8±1.4 for visuospatial abilities,
and 3.3±4.6 for executive function. Just over a quarter of all participants (26.4%) scored
≥ 8 on
the MBI-C (with higher scores denoting greater symptom burden). The mean severity of MBI-C
scores were 5.8±8.1 total, 1.8±2.7 for decreased motivation (apathy), 1.9±2.8 for affective
dysregulation (mood/anxiety symptoms), 1.6±2.5 for impulse dyscontrol (agitation, impulsivity,
abnormal reward salience), 0.3±0.8 for social inappropriateness (impaired social cognition), and
0.2±0.8 for psychosis (hallucinations and delusions). Finally, participants had an average IADL
total score of 0.8±1.8 (with higher scores denoting greater impairment), and EQ-5D total score of
6.9±2.0 (with higher scores denoting poor QoL).
. CC-BY-NC 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)preprint
The copyright holder for thisthis version posted December 17, 2023. ; https://doi.org/10.1101/2023.12.16.23300094doi: medRxiv preprint
14
A total of 536 participant-study partner dyads completed assessments for cognition,
behaviour, and quality of life. After controlling for participant and study partner age, sex, and
completed years of education, participant and study partner reported ECog-II total scores were
moderately correlated (Spearman’s r=0.30, p<.001), participant and study partner reported MBI-
C total scores were weakly correlated (Spearman’s r=0.27, p<.001), and participant and study
partner reported EQ-5D total scores were moderately-strongly correlated (Spearman’s r=0.53,
p<.001). In participants, every 1-unit rise in MBI-C total score was associated with a 0.1 SD
lower score on Trail-Making, Switching Stroop, Self-Ordered Search, Paired Associates
Learning, and Digit Span (all p<0.02). MBI-C total score was not associated with any change in
Verbal Reasoning performance (p=0.46). Negative binomial regressions revealed that every 1-
unit rise in MBI-C total score was also associated with a 5.6% (95%CI: 4.9-6.3, p<.001) greater
ECog-II total score, and 7.9% (95%CI: 6.0-9.9, p<.001) greater IADL total score.
Discussion
CAN-PROTECT is a Canada-wide online observational cohort study of brain aging. In
the first three months after launch, 2150 participants
≥ 40 years of age from all Canadian
provinces enrolled in the study; 637 of the study partners had completed assessments.
Engagement with the study was excellent, with many optional assessments completed in addition
to the mandatory ones. Preliminary analyses demonstrated relationships between cognition,
behaviour, function, and quality of life. These results speak to the feasibility of a large-scale
online study to obtain data relevant to brain aging, and to determine risk and resilience to
cognitive decline. The successful launch speaks to the public interest in studies with a focus on
the brain and cognition. This sample is ideal for studies of brain aging, dementia prevention, and
early detection of neurodegenerative disease. Several features of CAN-PROTECT are important
. CC-BY-NC 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)preprint
The copyright holder for thisthis version posted December 17, 2023. ; https://doi.org/10.1101/2023.12.16.23300094doi: medRxiv preprint
15
to consider in terms of assessing risk and resilience in Canadians, and for further development
and recruitment of a potentially research-ready cohort.
4.1 Neuropsychological Test Battery
The neuropsychological test battery proved feasible and informative in obtaining
Objective
information on cognitive performance across participants. Indeed, the assessment of
multiple cognitive domains is essential for comprehensive studies of brain aging. CAN-
PROTECT assessed the domains of attention, executive function, task switching, visual episodic
memory, verbal reasoning, and working memory. These tests serve as a baseline score for each
participant and can be used to determine norms for this Canada-wide sample and rates of change
over time. Importantly, because assessments are online, many assessments can be obtained in a
cost-effective manner, relative to conventional face-to-face testing. Further, flagging of
participants with a substantial drop in cognition can identify persons who may benefit from
prevention studies, both pharmacological and non-pharmacological. CAN-PROTECT has ethics
approval to contact participants for potential participation in such trials if they provide consent to
do so (~75% of participants in this sample consented).
4.2 Geographic Reach and Diversity
Participants were recruited from all Canadian provinces. Given this broad reach of CAN-
PROTECT, recruitment can further target sub-populations. Specifically, persons living in remote
regions or those far from academic centres, as well as ethnocultural minorities and racialized
Canadians are underrepresented in dementia research such that not enough is known about these
segments of the population. Targeted enrolment of these groups can prove informative about
. CC-BY-NC 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)preprint
The copyright holder for thisthis version posted December 17, 2023. ; https://doi.org/10.1101/2023.12.16.23300094doi: medRxiv preprint
16
brain aging in a more diverse population and inform future research and health services
implementation.
Relatedly, the approach to identification of diversity amongst participants is a unique
strength of CAN-PROTECT. The lack of participant diversity in dementia research results in
speculative generalizability to more diverse real-world populations. Part of the problem is
embedded in the arbitrary and vague descriptions or categorizations of ethnoracial groups in
study samples. For example, the U.S. Census operationalizes ethnoracial groups by using the
1997 Office of Management and Budget Standards, which informs many studies.[40] This
approach employs an archaic and reductionistic 5-class definition of race: White, Black or
African American, American Indian or Alaska Native, Native Hawaiian or Other Pacific
Islander, and Asian, with an “Other-specify” group (in which “multi-racial” can be written in).
Two options for ethnicities are offered, Hispanic and non-Hispanic, but can only be applied to
the White and Black race categories. This categorization, as often operationalized in dementia
cohorts, is not sensitive with within-group variability (e.g., lumping together the monolithic
Asian group) or to persons who identify and have been influenced by more than one group.
In CAN-PROTECT, the approach to ethnocultural and ethnoracial self-identification is
based on a cultural mosaic model[41] and the Statistics Canada definition of ethnic origin, i.e.,
the ethnic or cultural origins of the person's ancestors.[42] This approach allows a deeper
understanding of backgrounds than the more superficial construct of race and the “melting pot”
model seen elsewhere.[41] CAN-PROTECT categorizations are informed by the Canadian
Census descriptions of the ethnocultural groups in Canada.[42] These categories include: 1)
North American Aboriginal origins (First Nations, Inuit, Métis); 2) Other North American
origins; 3) European origins (British Isles, French, Western European, Northern European,
. CC-BY-NC 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)preprint
The copyright holder for thisthis version posted December 17, 2023. ; https://doi.org/10.1101/2023.12.16.23300094doi: medRxiv preprint
17
Eastern European, Southern European, Other); 4) Caribbean origins; 5) Latin, Central and South
American origins; 6) African origins (Central and West African, North African, Southern and
East African, Other); 7) Asian (West Central Asian and Middle Eastern, South Asian, East and
Southeast Asian, Other); 8) Oceania; and 9) Pacific Islands origins. Participants can multi-select
origins from drop down menus within each of the 9 categories.
Similarly, CAN-PROTECT takes a broad approach to religious affiliation, which may be
an important consideration when understanding health-related decision making, and family and
community inputs. Participants describe their affiliations with major Western religions, Eastern
religions, Aboriginal spirituality, Agnostic and Atheist beliefs.
Sex at birth is determined, as is gender identification, including man, woman, non-binary,
gender fluid, two-spirit, and other. Again, data are very sparse with respect to the roles of gender
and brain aging, and the inclusion of diversity of gender affiliations will allow better assessment
of gender over time. Nuanced assessments of gender may be important in understanding
caregiving roles, for example.
4.3 Feasibility
We demonstrated the feasibility of this study as an online platform to obtain information
on brain aging across the country. The high number of participants that have consented to
newsletters, contact for flagging for cognitive decline, and for future studies speak to the great
interest in brain aging amongst study participants. It also shows the ability for CAN-PROTECT
to serve not only as a platform to observe brain aging, but also for recruitment for additional
studies and trials.
4.4 Conclusions
. CC-BY-NC 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)preprint
The copyright holder for thisthis version posted December 17, 2023. ; https://doi.org/10.1101/2023.12.16.23300094doi: medRxiv preprint
18
CAN-PROTECT is the first Canadian study of its kind to capture near real-time
assessments of a broad spectrum of adult participants, paid caregivers, and informal care partners
of older adults with cognitive disorders. These data will inform the field and allow sophisticated
analyses on risk and resilience in aging. This research is inclusive and represents a Canada-wide
sample to optimize generalizability. Regarding caregiving, with increased recruitment the study
can determine the perceived burden attendant with caregiving, the status of the caregiver/care
partner, and factors which aid and exacerbate this burden. Further, paid caregivers, many of
whom are immigrant women, will be well-represented in this sample, providing novel insights
into this understudied group. Subsequent analyses will include participants younger than 40
years of age and explore the many novel assessments included in the study. With time, the
longitudinal data will allow assessments of change, and contribute to model building for risk and
resilience.
Conflict of Interest Statement:
The authors declare that they have no known competing financial interests or personal
relationships that could have appeared to influence the work reported in this paper.
Funding/Support Statement:
CAN-PROTECT was supported by Gordie Howe CARES. The funder did not influence study
design, collection, analysis, interpretation, writing, or decision to submit for publication.
Author Contributions:
All authors contributed to critical revisions of the final manuscript as well as study design, data
acquisition, and/or data analysis and interpretation. All authors provided approval for the final
submission.
. CC-BY-NC 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)preprint
The copyright holder for thisthis version posted December 17, 2023. ; https://doi.org/10.1101/2023.12.16.23300094doi: medRxiv preprint
19
References
[1] Prince MJ. World Alzheimer Report 2015: the global impact of dementia: an analysis of
prevalence, incidence, cost and trends: Alzheimer's Disease International; 2015.
[2] Gauthier S, Ismail Z, Goodarzi Z, Ng K, Rosa-Neto P. Clinicians’ Perspectives on How
Disease Modifying Drugs for Alzheimer’s Disease Impact Specialty Care. The Journal of
Prevention of Alzheimer's Disease. 2023:1-3.
[3] Montero-Odasso M, Zou G, Speechley M, Almeida QJ, Liu-Ambrose T, Middleton LE, et al.
Effects of Exercise Alone or Combined With Cognitive Training and Vitamin D
Supplementation to Improve Cognition in Adults With Mild Cognitive Impairment: A
Randomized Clinical Trial. JAMA Network Open. 2023;6:e2324465-e.
[4] Montero-Odasso M, Ismail Z, Livingston G. One third of dementia cases can be prevented
within the next 25 years by tackling risk factors. The case “for” and “against”. Alzheimers Res
Ther. 2020;12:1-5.
[5] Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, et al. Dementia
prevention, intervention, and care: 2020 report of the Lancet Commission. The Lancet.
2020;396:413-46.
[6] Kivipelto M, Ngandu T, Laatikainen T, Winblad B, Soininen H, Tuomilehto J. Risk score for
the prediction of dementia risk in 20 years among middle aged people: a longitudinal,
population-based study. The Lancet Neurology. 2006;5:735-41.
[7] Exalto LG, Quesenberry CP, Barnes D, Kivipelto M, Biessels GJ, Whitmer RA. Midlife risk
score for the prediction of dementia four decades later. Alzheimer's & Dementia. 2014;10:562-
70.
[8] Norton S, Matthews FE, Barnes DE, Yaffe K, Brayne C. Potential for primary prevention of
Alzheimer's disease: an analysis of population-based data. The Lancet Neurology. 2014;13:788-
94.
[9] Iso-Markku P, Waller K, Vuoksimaa E, Heikkilä K, Rinne J, Kaprio J, et al. Midlife physical
activity and cognition later in life: a prospective twin study. J Alzheimers Dis. 2016;54:1303-17.
[10] Covell GES, Hoffman-Snyder CR, Wellik KE, Woodruff BK, Geda YE, Caselli RJ, et al.
Physical activity level and future risk of mild cognitive impairment or dementia: a critically
appraised topic. The Neurologist. 2015;19:89-91.
[11] Cao L, Tan L, Wang H-F, Jiang T, Zhu X-C, Lu H, et al. Dietary patterns and risk of
dementia: a systematic review and meta-analysis of cohort studies. Mol Neurobiol.
2016;53:6144-54.
[12] Beydoun MA, Beydoun HA, Gamaldo AA, Teel A, Zonderman AB, Wang Y.
Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic
review and meta-analysis. BMC Public Health. 2014;14:1-33.
[13] North T-L, Palmer TM, Lewis SJ, Cooper R, Power C, Pattie A, et al. Effect of smoking on
physical and cognitive capability in later life: a multicohort study using observational and
genetic approaches. BMJ open. 2015;5:e008393.
[14] Deckers K, van Boxtel MP, Schiepers OJ, de Vugt M, Munoz Sanchez JL, Anstey KJ, et al.
Target risk factors for dementia prevention: a systematic review and Delphi consensus study on
the evidence from observational studies. Int J Geriatr Psychiatry. 2015;30:234-46.
[15] Di Santo SG, Franchini F, Filiputti B, Martone A, Sannino S. The effects of COVID-19 and
quarantine measures on the lifestyles and mental health of people over 60 at increased risk of
dementia. Frontiers in Psychiatry. 2020;11.
. CC-BY-NC 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)preprint
The copyright holder for thisthis version posted December 17, 2023. ; https://doi.org/10.1101/2023.12.16.23300094doi: medRxiv preprint
20
[16] Montine TJ, Cholerton BA, Corrada MM, Edland SD, Flanagan ME, Hemmy LS, et al.
Concepts for brain aging: resistance, resilience, reserve, and compensation. Alzheimers Res
Ther. 2019;11:1-3.
[17] Ferreira N, Owen A, Mohan A, Corbett A, Ballard C. Associations between cognitively
stimulating leisure activities, cognitive function and age
/i2 related cognitive decline. Int J Geriatr
Psychiatry. 2015;30:422-30.
[18] Ghahremani M, Smith EE, Chen HY, Creese B, Goodarzi Z, Ismail Z. Vitamin D
supplementation and incident dementia: Effects of sex, APOE, and baseline cognitive status.
Alzheimers Dement (Amst). 2023;15:e12404.
[19] Fratiglioni L, Marseglia A, Dekhtyar S. Ageing without dementia: can stimulating
psychosocial and lifestyle experiences make a difference? The Lancet Neurology. 2020;19:533-
43.
[20] Harrison SL, Sajjad A, Bramer WM, Ikram MA, Tiemeier H, Stephan BC. Exploring
strategies to operationalize cognitive reserve: A systematic review of reviews. J Clin Exp
Neuropsychol. 2015;37:253-64.
[21] Mantri S, Nwadiogbu C, Fitts W, Dahodwala N. Quality of education impacts late
/i2 life
cognition. Int J Geriatr Psychiatry. 2019;34:855-62.
[22] Karp A, Andel R, Parker MG, Wang H-X, Winblad B, Fratiglioni L. Mentally stimulating
activities at work during midlife and dementia risk after age 75: follow-up study from the
Kungsholmen Project. The American Journal of Geriatric Psychiatry. 2009;17:227-36.
[23] Brown CL, Robitaille A, Zelinski EM, Dixon RA, Hofer SM, Piccinin AM. Cognitive
activity mediates the association between social activity and cognitive performance: A
longitudinal study. Psychol Aging. 2016;31:831.
[24] Oosterhuis EJ, Slade K, May PJC, Nuttall HE. Toward an Understanding of Healthy
Cognitive Aging: The Importance of Lifestyle in Cognitive Reserve and the Scaffolding Theory
of Aging and Cognition. The Journals of Gerontology: Series B. 2023;78:777-88.
[25] Huntley J, Corbett A, Wesnes K, Brooker H, Stenton R, Hampshire A, et al. Online
assessment of risk factors for dementia and cognitive function in healthy adults. Int J Geriatr
Psychiatry. 2018;33:e286-e93.
[26] Roach P, Zwiers A, Cox E, Fischer K, Charlton A, Josephson CB, et al. Understanding the
impact of the COVID-19 pandemic on well-being and virtual care for people living with
dementia and care partners living in the community. Dementia (London). 2021;20:2007-23.
[27] Reitan RM. Validity of the Trail Making Test as an indicator of organic brain damage.
Percept Mot Skills. 1958;8:271-6.
[28] Stroop JR. Studies of interference in serial verbal reactions. J Exp Psychol. 1935;18:643.
[29] Owen AM, Downes JJ, Sahakian BJ, Polkey CE, Robbins TW. Planning and spatial
working memory following frontal lobe lesions in man. Neuropsychologia. 1990;28:1021-34.
[30] Owen AM, Beksinska M, James M, Leigh PN, Summers BA, Marsden CD, et al.
Visuospatial memory deficits at different stages of Parkinson's disease. Neuropsychologia.
1993;31:627-44.
[31] Baddeley AD. A 3 min reasoning test based on grammatical transformation. Psychon Sci.
1968;10:341-2.
[32] Huntley JD, Hampshire A, Bor D, Owen A, Howard RJ. Adaptive working memory strategy
training in early Alzheimer's disease: Randomised controlled trial. The British Journal of
Psychiatry. 2017;210:61-6.
. CC-BY-NC 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)preprint
The copyright holder for thisthis version posted December 17, 2023. ; https://doi.org/10.1101/2023.12.16.23300094doi: medRxiv preprint
21
[33] Farias ST, Weakley A, Harvey D, Chandler J, Huss O, Mungas D. The Measurement of
Everyday Cognition (ECog): Revisions and Updates. Alzheimer Dis Assoc Disord. 2021;35:258-
64.
[34] Ismail Z, Agüera-Ortiz L, Brodaty H, Cieslak A, Cummings J, Fischer CE, et al. The Mild
Behavioral Impairment Checklist (MBI-C): a rating scale for neuropsychiatric symptoms in pre-
dementia populations. Journal of Alzheimer's disease. 2017;56:929-38.
[35] Hu S, Patten S, Charlton A, Fischer K, Fick G, Smith EE, et al. Validating the Mild
Behavioral Impairment Checklist in a Cognitive Clinic: Comparisons With the Neuropsychiatric
Inventory Questionnaire. J Geriatr Psychiatry Neurol. 2023;36:107-20.
[36] Mallo SC, Ismail Z, Pereiro AX, Facal D, Lojo-Seoane C, Campos-Magdaleno M, et al.
Assessing Mild Behavioral Impairment with the Mild Behavioral Impairment-Checklist in
People with Mild Cognitive Impairment. Journal of Alzheimer's Disease. 2018;66:83-95.
[37] Mallo SC, Ismail Z, Pereiro AX, Facal D, Lojo-Seoane C, Campos-Magdaleno M, et al.
Assessing mild behavioral impairment with the mild behavioral impairment checklist in people
with subjective cognitive decline. Int Psychogeriatr. 2019;31:231-9.
[38] Morris JN, Morris SA. ADL assessment measures for use with frail elders. J Ment Health
Aging. 1997;3:19-46.
[39] Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and
preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res.
2011;20:1727-36.
[40] Anderson M, Fienberg SE. Race and ethnicity and the controversy over the US Census.
Current Sociology. 2000;48:87-110.
[41] Chuapetcharasopon P, Neville L, Adair WL, Brodt SE, Lituchy TR, Racine AA. Cultural
mosaic beliefs as a new measure of the psychological climate for diversity: Individual
distinctiveness and synergy in culturally diverse teams. International Journal of Cross Cultural
Management. 2018;18:7-32.
[42] Canada S. Census of Population Appendix 5.1 Ethnic origins disseminated from 2016, 2011
and 2006. 2016.
[43] Jorm AF. A short form of the Informant Questionnaire on Cognitive Decline in the Elderly
(IQCODE): development and cross-validation. Psychol Med. 1994;24:145-53.
[44] Kroenke K, Spitzer RL, Williams JB. The PHQ
/i2 9: validity of a brief depression severity
measure. J Gen Intern Med. 2001;16:606-13.
[45] Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized
anxiety disorder: the GAD-7. Arch Intern Med. 2006;166:1092-7.
[46] Russell DW. UCLA Loneliness Scale (Version 3): Reliability, validity, and factor structure.
J Pers Assess. 1996;66:20-40.
[47] Thase ME, Ismail Z, Meehan SR, Weiss C, Regnier SA, Larsen KG, et al. Assessment of
patient life engagement in major depressive disorder using items from the Inventory of
Depressive Symptomatology Self-Report (IDS-SR). J Psychiatr Res. 2023;161:132-9.
[48] Marzona I. The Standard Assessment of Global Activities in the Elderly (SAGE) Scale:
validation process of a new tool for the assessment of disability in older adults 2011.
[49] Dams-O’Connor K, Cantor JB, Brown M, Dijkers MP, Spielman LA, Gordon WA.
Screening for traumatic brain injury: findings and public health implications. The Journal of head
trauma rehabilitation. 2014;29:479.
. CC-BY-NC 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)preprint
The copyright holder for thisthis version posted December 17, 2023. ; https://doi.org/10.1101/2023.12.16.23300094doi: medRxiv preprint
22
GRAPHICS
Table 1. CAN-PROTECT Study Assessments
Assessment Baseline/
Annual
Completed by
Self/Study
Partner/Both
Description
Cognitive test battery* Annuala Self
Trail-Making B
Examines visual attention and task switching.[27]
Participants are required to connect sequential
numbers and letters (e.g. A-1-B-2 etc.) to create a
continuous trail. This is a validated measure of
executive function. Errors made lead to a lower
score, and the test is time limited.
Switching Stroop
Examines visual attention and task switching.[28]
Participants are required to name the ink colour of a
series of words which are presented while ignoring
the semantic meaning of the word itself. This is a
widely used measure of executive function and is
highly sensitive to early cognitive deficit.
Self-Ordered-Search
Examines spatial working memory.[29] Participants
are required to search a series of on-screen boxes to
find a hidden symbol. Once found, participants
search for a new symbol, remembering that a
symbol will never be hidden in the same box twice.
The main outcome is the average number of boxes
in the successfully completed trials.
Paired Associate Learning
Examines visual episodic memory.[30] Participants
are required to see a series of objects, one at a time,
and select the correct location of each object in
“windows” they had previously been shown. This
version uses a ratchet style approach. The main
outcome measure is the average number of correct
object-place associations (“paired associates”) in the
trials that were successfully completed. Participants
are allowed 3 errors before the test terminates.
Verbal Reasoning
Examines general intelligence and reasoning.[31]
Participants are required to determine the accuracy
of a series of grammatical statements about a
picture. The outcome measure is the total number of
trials answered correctly in 90 seconds, minus the
. CC-BY-NC 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)preprint
The copyright holder for thisthis version posted December 17, 2023. ; https://doi.org/10.1101/2023.12.16.23300094doi: medRxiv preprint
23
number answered incorrectly.
Digit Span
Examines working memory.[32] Participants are
required to view a series of numbers and then select
the numbers in the correct order from a numeric
keypad. The test uses a ratchet-style approach in
which each successful trial is followed by a new
sequence that is 1 digit longer than the last and each
unsuccessful trial is followed by a new sequence
that is 1 digit shorter than the last. This allows an
accurate estimate of digit span to be made quickly.
The main outcome measure is the average number
of digits in all successfully completed trials.
Demographics* Baselineb Both A detailed questionnaire about participant age, sex,
gender, marital status, ethnocultural identification,
religious affiliation, education level, language,
employment, and cognitive reserve.
Everyday cognition* Annual Both A composite questionnaire about subjective or
observed cognitive symptoms in the participant.
Tests include the revised ECog-II[33] (self-reported
cognition and function) and IQCODE[43] (self-
report of cognitive change) scales.
Everyday emotions* Annual Both c A composite questionnaire about participant status
with regard to emotions, behaviours, and
neuropsychiatric symptoms. Tests include the PHQ-
9[44] (depression), CADI (anxious distress), GAD-
7[45] (anxiety), MBI-C[34] (global neuropsychiatric
symptoms), and 3-item UCLA loneliness scale[46].
Everyday activities* Annual Self A questionnaire about the participant status with
regard to instrumental activities of daily living.[38]
Medical history* Annual Self A questionnaire about the participant height and
weight, handedness, existing medical conditions,
and types of medications and supplements.
. CC-BY-NC 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)preprint
The copyright holder for thisthis version posted December 17, 2023. ; https://doi.org/10.1101/2023.12.16.23300094doi: medRxiv preprint
24
Quality of life* Annual Both A composite questionnaire about participant status
with regard to quality, satisfaction, and engagement
with life. Tests include QFS-5 (quality of life), EQ-
5D[39] (quality of life), IDS-SR[47] (engagement),
and Cantril Ladder (satisfaction).
Fertility/menopause* Annual Selfc A questionnaire to capture past and current
information about fertility and menopause including
menopausal onset, peri-menopausal symptoms,
hormone replacement therapy, and infertility.
Daily function* Annual Both A questionnaire about self-reported and observed
functional abilities of the participant. Items come
from the SAGEA[48] scale for overall function in
daily life.
COVID-19 Baseline Self A questionnaire about COVID-19 impacts (mental
health, physical health, coping strategies)
exposure/diagnostic status, and vaccination status.
Diet Annual Self A questionnaire about style of diet (e.g., Western,
Mediterranean, Keto, etc.) and types of foods
consumed.
Family history Baseline Self A questionnaire that captures detailed family history
of dementia, including dementia sub-types in
individual family members.
Brain injury screening Baselineb Self A detailed questionnaire on history of concussions
and head injuries, including severity and settings in
which they occurred. Items come from the Brain
Injury Screening Questionnaire – Short[49] form.
Lifestyle Annual Self A questionnaire about current amount and type of
exercise, smoking and alcohol status, use of
technology, current use of cognitive remediation or
brain training.
Activities-specific balance
confidence
Annual Self A questionnaire about balance in older adults.
Mental health Baseline Self A questionnaire about past history of mental health
symptoms and diagnoses, and childhood
experiences.
Perceived health feelings and
attitudes toward aging
Annual Self A questionnaire about self-perceptions of aging.
. CC-BY-NC 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)preprint
The copyright holder for thisthis version posted December 17, 2023. ; https://doi.org/10.1101/2023.12.16.23300094doi: medRxiv preprint
25
Physical fitness Annual Self A questionnaire about the participant’s performance
on a series of video-led tasks designed to give a
robust measure of current physical fitness.
Chair Stand Test Self A video-led physical task that requires participants
to raise from sitting to standing as many times as
possible within 30 seconds.
Timed Chair-Stand Test Self A video-led physical task that requires participants
to raise from sitting to standing 10 times as fast as
possible.
Two-Minute Step Test Self A video-led physical task that requires participants
to march on the spot as many times as possible in
two minutes.
Gait Velocity Self Participants rank their walking speed using a tick-
box selection.
Caregiver work history and
roles
Annual Self d A questionnaire about past history and current status
in paid caregiver roles.
Caregiver stress scale Annual Self d A questionnaire about the experiences of stress in
paid caregivers.
Care partner resources and
supports
Annual Self d A questionnaire about the resources and supports
available for caregivers and their entry to care
provision.
Care partner stress scale Annual Self d A questionnaire about the experiences of stress in
care partners of persons with dementia.
Participant health Annual Study partner A questionnaire about the participant’s health as
reported by the study partner.
a Cognitive test battery is assessed three times per year and must be completed within one week (at least 12 hours
apart). Only completion of the first of three cognitive test batteries is mandatory.
b Administered at baseline but open for editing should answers change.
c Only MBI-C and 3-item UCLA loneliness scale administered to study partner.
d Only available for participants who are registered in the caregiver sub-study.
* Indicates mandatory assessment.
Abbreviations: ECog-II, revised Everyday Cognition scale; IQCODE, Informant Questionnaire on Cognitive Decline
in the Elderly; PHQ-9, Patient Health Questionnaire-9; CADI, Calgary Anxious-Distress Inventory; GAD-7,
Generalized Anxiety Disorder-7; MBI-C, Mild Behavioral Impairment Checklist; UCLA, University of California
Los Angeles; QFS-5, Quality of Life and Function Self-Report; EQ-5D, EuroQol-5D; IDS-SR, Inventory of
Depressive Symptomatology Self-Report; SAGE, Standard Assessment of Global Everyday Activities.
. CC-BY-NC 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)preprint
The copyright holder for thisthis version posted December 17, 2023. ; https://doi.org/10.1101/2023.12.16.23300094doi: medRxiv preprint
26
Table 2. Baseline CAN-PROTECT Participant, Caregiver, and Study Partner Characteristics
Variable Participant Caregiver Study Partnera
n 2150 50 637
Age (years) 62.9 (9.3), 40-91 61.4 (8.6), 47-81 58.5 (13.9), 19-87
Sex
Female 1669 (77.6) 42 (84.0) 347 (54.5)
Male 481 (22.4) 8 (16.0) 290 (45.5)
Gender
Woman 1667 (77.5) 42 (84.0) 346 (54.3)
Man 480 (22.3) 8 (16.0) 285 (44.7)
Non-binary 1 (0.0) 0 (0.0) 3 (0.5)
Other 2 (0.1) 0 (0.0) 2 (0.3)
Education (years) 15.8 (5.8), 0-85 15.8 (3.9), 6-24 15.6 (6.6); 1-78
Language
English 1979 (92.0) 46 (92.0)
French 51 (2.4) 0 (0.0)
Other 120 (5.6) 4 (8.0)
Handedness
Right 1864 (86.7) 45 (90.0)
Left 236 (11.0) 4 (8.0)
Ambidextrous 50 (2.3) 1 (2.0)
Marital Status
Married 1488 (69.2) 39 (78.0) 491 (77.1)
Other 662 (30.8) 11 (22.0) 146 (22.9)
Ethnocultural Groupb
North America 1058 (49.2) 23 (46.0) 303 (47.6)
First Nations 34 (3.2) 0 (0.0) 7 (2.3)
Inuit 1 (0.1) 0 (0.0) 0 (0.0)
Métis 36 (3.4) 1 (4.3) 11 (3.6)
Canada 965 (91.2) 22 (95.7) 280 (92.4)
United States 68 (6.4) 1 (4.3) 12 (4.0)
Europe 1802 (83.8) 41 (82.0) 544 (85.4)
Caribbean 23 (1.1) 1 (2.0) 4 (0.6)
South America 20 (0.9) 0 (0.0) 4 (0.6)
Africa 19 (0.9) 1 (2.0) 5 (0.8)
Asia 68 (3.2) 2 (4.0) 23 (3.6)
Oceania 13 (0.6) 0 (0.0) 4 (0.6)
Cognitive Testsc
Trail-Making 62.3 (24.0), 22.1-333.1 54.6 (16.8), 28.9-95.5
Switching Stroop 38.1 (15.0), 0-86.0 42.9 (15.9), 18.0-74.0
Self-Ordered Search 6.5 (2.7), 0-13 6.8 (2.5), 0-9.7
Paired Associates Learning 3.9 (0.9), 0-7.3 4.1 (0.7), 2.0-5.3
Verbal Reasoning 31.4 (10.0), -1.5-70.0 35.8 (10.9), 9.0-67.0
Digit Span 6.9 (1.9), 0-20.0 7.2 (1.8), 2.0-11.3
ECog-II
Total 12.0 (11.5), 0-88 9.9 (9.5), 0-48 7.5 (11.7), 0-108
Memory 4.7 (3.9), 0-24 3.8 (3.1), 0-14 2.9 (4.0), 0-27
Language 3.2 (3.5), 0-24 2.5 (2.8), 0-13 1.5 (2.9), 0-27
Visuospatial Abilities 0.8 (1.4), 0-14 0.5 (0.8), 0-3 0.7 (1.8), 0-19
Executive Function 3.3 (4.6), 0-35 3.1 (5.0), 0-29 2.5 (4.4), 0-39
MBI-C Score ≥ 8d 383 (26.4) 18 (36.0) 104 (16.3)
MBI-C Severity
Global 5.8 (8.1), 0-65 7.9 (8.5), 0-41 4.0 (6.3), 0-45
Decreased Motivation 1.8 (2.7), 0-18 2.6 (3.1), 0-13 0.9 (2.0), 0-14
Affective Dysregulation 1.9 (2.8), 0-18 3.0 (2.9), 0-15 1.4 (2.2), 0-14
Impulse Dyscontrol 1.6 (2.6), 0-20 1.8 (2.7), 0-10 1.3 (2.4), 0-18
. CC-BY-NC 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)preprint
The copyright holder for thisthis version posted December 17, 2023. ; https://doi.org/10.1101/2023.12.16.23300094doi: medRxiv preprint
27
Social Inappropriateness 0.3 (0.8), 0-9 0.3 (0.7), 0-3 0.2 (0.6), 0-5
Psychosis 0.2 (0.7), 0-6 0.2 (0.5), 0-3 0.1 (0.4), 0-3
IADL Total Score 0.8 (1.8), 0-15 0.4 (1.2), 0-7
EQ-5D Total Score 6.9 (2.0), 5-19 7.5 (2.2), 5-15 7.0 (2.1), 5-20
a Only demographic variables pertain to the study partner. ECog-II, MBI-C, and EQ-5D values reported in the
study partner column indicate scores for the participant as reported by the study partner. Some study partners may
also be study participants.
b Participant and study partner are given the opportunity to identify as more than one ethnocultural group.
Categories are not mutually exclusive.
c Because participants can complete the cognitive test battery up to three times per year, scores from all
completed cognitive tests scores were averaged within participants before being averaged across participants to
generate values reported here.
d An MBI-C total score ≥ 8 is a validated cut-off to define older adults as having MBI.[36, 37] Because cut-off
scores have not yet been validated for each MBI-C domain, prevalence rates of each MBI domain are not
presented.
Numeric variables are reported in mean (standard deviation), range. Categorical variables are reported in n (%)
for each level. Abbreviations: ECog-II, revised Everyday Cognition scale; MBI-C, Mild Behavioral Impairment
Checklist; EQ-5D, EuroQol-5D; IADL, Instrumental activities of daily living.
. CC-BY-NC 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)preprint
The copyright holder for thisthis version posted December 17, 2023. ; https://doi.org/10.1101/2023.12.16.23300094doi: medRxiv preprint
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.